| Danielle Batsch, CRNA | |
|
18701 N 67th Ave, Glendale, AZ 85308-7100 | |
| (623) 561-1000 | |
| Not Available |
| Full Name | Danielle Batsch |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 18701 N 67th Ave, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649940586 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 262690 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Arrowhead Hospital | Glendale, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greater Anesthesia Solutions | 9234357906 | 155 |
News Archive
A recent study by a University of Northern British Columbia-based scientist associated with the UBC Faculty of Medicine and UNBC's Northern Medical Program demonstrates that Canada's drinking-age laws have a significant effect on youth mortality.
"Brazilian researchers say they have successfully tested a vaccine against schistosomiasis, a disease caused by parasitic worms that afflicts more than 200 million people worldwide," Agence France-Presse reports.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
New research from The Johns Hopkins University suggests that a molecule commonly found "decorating" brain cells in higher animals, including humans, may affect brain structure.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established yet another agreement with a large biotechnology company for the evaluation of a novel oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
› Verified 9 days ago
| Entity Name | Greater Anesthesia Solutions |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124430244 PECOS PAC ID: 9234357906 Enrollment ID: O20140822000525 |
News Archive
A recent study by a University of Northern British Columbia-based scientist associated with the UBC Faculty of Medicine and UNBC's Northern Medical Program demonstrates that Canada's drinking-age laws have a significant effect on youth mortality.
"Brazilian researchers say they have successfully tested a vaccine against schistosomiasis, a disease caused by parasitic worms that afflicts more than 200 million people worldwide," Agence France-Presse reports.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
New research from The Johns Hopkins University suggests that a molecule commonly found "decorating" brain cells in higher animals, including humans, may affect brain structure.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established yet another agreement with a large biotechnology company for the evaluation of a novel oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Batsch, CRNA 18651 N 70th Ave, Glendale, AZ 85308-5786 Ph: (720) 938-0584 | Danielle Batsch, CRNA 18701 N 67th Ave, Glendale, AZ 85308-7100 Ph: (623) 561-1000 |
News Archive
A recent study by a University of Northern British Columbia-based scientist associated with the UBC Faculty of Medicine and UNBC's Northern Medical Program demonstrates that Canada's drinking-age laws have a significant effect on youth mortality.
"Brazilian researchers say they have successfully tested a vaccine against schistosomiasis, a disease caused by parasitic worms that afflicts more than 200 million people worldwide," Agence France-Presse reports.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
New research from The Johns Hopkins University suggests that a molecule commonly found "decorating" brain cells in higher animals, including humans, may affect brain structure.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established yet another agreement with a large biotechnology company for the evaluation of a novel oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
› Verified 9 days ago
Ms. Terren Courtney Wortham, DNP, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 623-561-1000 | |
Juan N Aliaga, DNP, APRN-CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 623-561-1000 | |
Jason Scott Herndon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 623-561-1000 | |
Camarae Mikaela Mather, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 602-653-3012 | |
Stephen Patrick Standish, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5901 W Behrend Dr Apt 1155, Glendale, AZ 85308 Phone: 206-372-7032 | |
Kenneth Michael Bania, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 623-561-1000 | |
Aaron Morrow, PHARMD Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 19410 N 68th Ave, Glendale, AZ 85308 Phone: 505-710-6292 |